GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (XSWX:YPSN) » Definitions » Cash-to-Debt

Ypsomed Holding AG (XSWX:YPSN) Cash-to-Debt : No Debt (1) (As of Sep. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Ypsomed Holding AG's cash to debt ratio for the quarter that ended in Sep. 2023 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Ypsomed Holding AG could pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Ypsomed Holding AG's Cash-to-Debt or its related term are showing as below:

XSWX:YPSN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06   Med: 2.14   Max: No Debt
Current: 0.23

During the past 13 years, Ypsomed Holding AG's highest Cash to Debt Ratio was No Debt. The lowest was 0.06. And the median was 2.14.

XSWX:YPSN's Cash-to-Debt is ranked worse than
84.69% of 862 companies
in the Medical Devices & Instruments industry
Industry Median: 1.935 vs XSWX:YPSN: 0.23

Ypsomed Holding AG Cash-to-Debt Historical Data

The historical data trend for Ypsomed Holding AG's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Ypsomed Holding AG Cash-to-Debt Chart

Ypsomed Holding AG Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 0.12 0.10 0.06 0.16

Ypsomed Holding AG Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.06 No Debt 0.16 No Debt

Competitive Comparison of Ypsomed Holding AG's Cash-to-Debt

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Cash-to-Debt falls into.



Ypsomed Holding AG Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Ypsomed Holding AG's Cash to Debt Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Ypsomed Holding AG's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Ypsomed Holding AG had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG  (XSWX:YPSN) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Ypsomed Holding AG Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (XSWX:YPSN) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (XSWX:YPSN) Headlines

No Headlines